Skip to main content
Premium Trial:

Request an Annual Quote

Fisher Scientific Snaps Up Dharmacon for $80M

NEW YORK, Feb. 12 (GenomeWeb News) - Bio-research supplier Fisher Scientific International will acquire RNAi provider Dharmacon for $80 million in cash, the companies said yesterday.

 

Dharmacon provides small interfering RNA technology and products. The company expects Fisher Scientific to maintain its facilities in Lafayette, Colo. Its shareholders will receive cash for all outstanding shares and option.

 

Fisher expects the acquisition, which has been approved by the boards of directors of both companies, to close by the end of March.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.